BiotechTube
Cambridge Analytical Laboratories

Cambridge Analytical Laboratories

Cambridge, United Kingdom· Est.
camclinlabs.co.uk
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Cambridge Clinical Laboratories (CCL), founded in 2005 and acquired by Source BioScience in April 2025, is a specialised diagnostics service provider based in Cambridge, UK. The company offers a portfolio of UKAS-accredited, personalised healthcare tests, with a strong focus on oncology (e.g., prostate, breast, lung cancer) and molecular diagnostics for healthcare professionals and organisations. Its integration into Source BioScience aims to create an end-to-end laboratory service portfolio, combining genomics, digital pathology, and clinical trial support. CCL's model is exclusively B2B, serving clinicians and healthcare providers to support patient diagnosis, treatment, and monitoring.

Oncology

Technology Platform

Service laboratory utilising molecular diagnostics, next-generation sequencing (NGS), pharmacogenetic testing, and virology diagnostics. Integrated into Source BioScience's broader genomics, multi-omics, and digital pathology platform.

Opportunities

Integration with Source BioScience allows CCL to offer a complete, end-to-end testing portfolio for healthcare and pharma R&D, expanding its market.
The growing emphasis on early cancer detection and personalised medicine in the NHS and private sector drives demand for its specialised diagnostic services.
Partnerships with private healthcare providers (e.g., Goodbody Clinic) enable indirect access to the consumer market for select screening tests.

Risk Factors

Temporary lapse in UKAS accreditation during lab relocation poses regulatory and client confidence risks.
Post-acquisition integration with Source BioScience must be managed carefully to avoid service disruption.
The company faces intense competition in the fast-evolving diagnostics market and is reliant on the budgetary and policy environment of the NHS.

Competitive Landscape

CCL competes in the crowded UK clinical diagnostics market against large national labs (e.g., The Doctors Laboratory, Viapath), hospital NHS labs, and other specialised private providers. Its differentiation lies in its focus on personalised healthcare, oncology expertise, and, post-acquisition, its integration into Source BioScience's broader genomic and pathology service platform. Competition is based on test accuracy, turnaround time, cost, service quality, and technological sophistication.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →